Yukiko Washio
Petal Petersen Williams
Krystyna R. Isaacs- 1Substance Use, Gender and Applied Research, RTI (Research Triangle Institute) International, Research Triangle Park, NC, United States
- 2Department of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States
- 3Mental Health, Alcohol, Substance Use and Tobacco Research Unit, South African Medical Research Council, Cape Town, South Africa
- 4Department of Health Sciences, University of York, York, United Kingdom
- 5Department of Global Health, Institute for Life Course Health Research, Stellenbosch University, Cape Town, South Africa
- 6SciConsult Solutions, Coppell, TX, United States
Editorial on the Research Topic
Maternal substance and alcohol use and contextual issues
Recent research advancements have delineated the impact of perinatal substance and alcohol use on the health of mothers and fetuses/infants (1–3) and also the bidirectional impact between perinatal substance and alcohol use and contextual issues (4–10). Adverse effects of perinatal substance and alcohol use include miscarriage, intrauterine growth restriction, low birth weight, shorter gestational weeks, increases in NICU admission, and stillbirth (1, 11–15). Recent evidence also identified independent adverse effects of breastfeeding while using alcohol on infant neurocognitive and physical development (16). This is concerning given the fact that even among people who stop drinking during pregnancy, many will return to drinking post-partum. A paucity of evidence about drinking during breastfeeding and few recommendations contribute to this phenomenon (17).
When perinatal substance and alcohol use occurs, there are often co-occurring psychosocially and culturally relevant contextual issues, such as socioeconomic disadvantage, lack of social support, trauma exposure, and depression (18–20). Given the significant involvement of perinatal substance and alcohol use in compromised sexual health (7, 21), these intertwined physical and mental health issues are clustered as a SAVA syndemic (substance abuse, violence, and AIDS) (22).
While using a single substance or alcohol during perinatal periods leads to pregnancy, birth, and infant complications (1, 2, 23–27), combined use of substances and alcohol use could further exacerbate their adverse effects on maternal-infant health (18–20, 28, 29). Because of continued cannabis legalization (30), an increase in perinatal cannabis use is a concern (31) (25, 26). The consequences of legalizing cannabis need to be delineated for pregnant and breastfeeding people (32–35).
The opioid epidemic in the United States (US) has led to a significant increase in perinatal opioid use (36). On top of this, the prevalence of overall perinatal substance and alcohol use as well as relevant contextual issues including violence exposure and maternal depression and anxiety has worsened since the global COVID-19 pandemic (37–42).
The current Research Topic, Maternal Substance and Alcohol Use and Contextual Issues, therefore focused on a set of qualitative and quantitative studies on maternal substance and alcohol use and associated contextual issues, with the goal of proposing new approaches to provide evidence-based information and treatment interventions. This Research Topic demonstrates a diversity in study settings, types of studies, and topic focus. The settings include Poland, South Africa, and the Philippines, in addition to the United States. The studies included both qualitative and quantitative research, and ranged from pilot and usability testing studies, to systematic reviews, to survey research. The topics included prenatal substance and alcohol use, stigma and mental health issues among pregnant and parenting people, and postpartum smoking relapse and substance use.
Two qualitative studies from South Africa (Petersen Williams et al., Petersen Williams et al.) investigated the development of interventions to encourage alcohol abstinence during pregnancy and breastfeeding. In both studies, the need for an alcohol intervention program was highlighted and informed the adaptation process for interventions that are culturally relevant and acceptable to the needs of the local context. Another study (Nguyen et al.) examined knowledge, attitudes, practices, and beliefs regarding prenatal alcohol consumption. Of particular interest in this study conducted in the Philippines (Huang et al.) was the widespread consumption (75%) of a local alcoholic beverage during pregnancy, which was believed to not contain alcohol and, in some instances, even fed to infants. Encouragingly, nearly all mothers (98%) were willing to reduce consumption when told that the practice negatively impacts pregnancies. An intervention study in Poland (Okulicz-Kozaryn et al.) aimed to reduce the risk of prenatal alcohol exposure in the general population of women of childbearing age including reduction of risky alcohol consumption, increasing effective contraception use, and increasing use of professional support to address the complex psychological, medical and social challenges which may increase risk of alcohol use during pregnancy. Follow-up data indicated that risky alcohol consumption dropped by 81%; contraception use increased by 15% and visiting a gynecologist increased by 39%. The most prominent changes were observed in the moderate-risk group.
Opioid use disorder is a leading cause of pregnancy-associated deaths. One study in the United States (Nguyen et al.) found that among patients who were incarcerated and initiated buprenorphine (BUP) treatment, the majority (97%) remained on BUP at delivery compared to those who were not incarcerated at BUP initiation (79%). Pregnant and parenting women recovering from substance use disorder (SUD) are at risk of insufficient recovery support. Another US study (Isaacs et al.) tested the usability and acceptability of a Plan of Safe Care (POSC) platform which combined a mobile health app with a web-based case management system. Family services staff, treatment center staff, and mothers with SUD rated the platform as usable and acceptable. A qualitative study (Young-Wolff et al.) in the US found that coping with mental health symptoms and stress were identified as drivers of perceived COVID-19 pandemic-related increases in prenatal cannabis use in 2021.
Researchers in the US evaluated the delivery of attentional retraining (AR) for smoking cues in perinatal smokers, also utilizing a mobile intervention (Forray et al.). They found evidence that AR reduced attentional bias compared with controls but found no evidence that AR reduced craving or smoking during the study period.
Some of the contextual issues to do with maternal substance use were also addressed in the Research Topic. In a systematic review and meta-analysis (Pacho et al.), the authors provided evidence of an increased risk of postpartum depression among pregnant substance users, and this was particularly the case for those using multiple substances or tobacco.
Stigma remains a huge barrier to receiving care for SUD, particularly among pregnant and parenting people. Another US study (Lipsett et al.) explored stigma reduction practices within the research community that can increase the uptake of evidence-based treatment programs and proposed six strategies for this to happen.
The collection of these publications gives us a glimpse of what is known about maternal substance and alcohol use and relevant contextual issues and what are the future research directions that subsequent studies need to follow.
Author contributions
YW: Conceptualization, Writing – original draft, Writing – review & editing. PP: Conceptualization, Writing – review & editing. KI: Writing – review & editing.
Conflict of interest
Author KI was employed by the company SciConsult Solutions.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Bailey BA, Sokol RJ. Prenatal alcohol exposure and miscarriage, stillbirth, preterm delivery, and sudden infant death syndrome. Alcohol Res Health. (2011) 34(1):86–91.
2. Addila AE, Azale T, Gete YK, Yitayal M. The effects of maternal alcohol consumption during pregnancy on adverse fetal outcomes among pregnant women attending antenatal care at public health facilities in Gondar town, Northwest Ethiopia: a prospective cohort study. Subst Abuse Treat Prev Policy. (2021) 16:1–15. doi: 10.1186/s13011-021-00401-x
3. Bukiya AN, Ali DW. Editorial: Substance abuse and early development. Adv Drug Alcohol Res. (2023) 3:11836. doi: 10.3389/adar.2023.11836
4. Skagerstrom J, Chang G, Nilsen P. Predictors of drinking during pregnancy: a systematic review. J Womens Health (Larchmt). (2011) 20:901–13. doi: 10.1089/jwh.2010.2216
5. Davis EC, Rotheram-Borus MJ, Weichle TW, Rezai R, Tomlinson M. Patterns of alcohol abuse, depression, and intimate partner violence among township mothers in South Africa over 5 years. AIDS Behav. (2017) 21:174–82. doi: 10.1007/s10461-017-1927-y
6. Myers B, Koen N, Donald KA, Nhapi RT, Workman L, Barnett W, et al. Effect of hazardous alcohol use during pregnancy on growth outcomes at birth: findings from a South African cohort study. Alcohol Clin Exp Res. (2018) 42:369–77. doi: 10.1111/acer.13566
7. Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: A literature review of the syndemic. J Womens Health. (2011) 20:991–1006. doi: 10.1089/jwh.2010.2328
8. Illangasekare S, Burke J, McDonnell K, Gielen A. The impact of intimate partner violence, substance use, and HIV on depressive symptoms among abused low-income urban women. J Interpers Viol. (2013) 28:2831–48. doi: 10.1177/0886260513488682
9. Cannon MJ, Dominique Y, O’Leary L, Sniezek JE, Floyd RL. Characteristics and behaviors of mothers who have a child with fetal alcohol syndrome. Neurotoxicol Teratol. (2012) 34:90–5. doi: 10.1016/j.ntt.2011.09.010
10. May PA, Gossage JP, Marais AS, Hendricks LS, Snell CL, Tabachnick BG, et al. Maternal risk factors for fetal alcohol syndrome and partial fetal alcohol syndrome in South Africa: a third study. Alcohol Clin Exp Res. (2008) 32:738–53. doi: 10.1111/j.1530-0277.2008.00634.x
11. Williams JF, Smith VC. the committee on substance abuse. Fetal alcohol spectrum disorders. Pediatrics. (2015) 136:11. doi: 10.1542/peds.2015-3113
12. Cornman-Homonoff J, Kuehn D, Aros S, Carter TC, Conley MR, Troendle J, et al. Heavy prenatal alcohol exposure and risk of stillbirth and preterm delivery. J Matern Fetal Neonatal Med. (2012) 25:860–3. doi: 10.3109/14767058.2011.587559
13. Meyer-Leu Y, Lemola S, Daeppen JB, Deriaz O, Gerber S. Association of moderate alcohol use and binge drinking during pregnancy with neonatal health. Alcohol Clin Exp Res. (2011) 35:1669–77. doi: 10.1111/j.1530-0277.2011.01513.x
14. Silva I, Quevedo Lde A, Silva RA, Oliveira SS, Pinheiro RT. Association between alcohol abuse during pregnancy and birth weight. Rev Saude Publica. (2011) 45:864–9. doi: 10.1590/S0034-89102011005000062
15. CDC. Fetal Alcohol Spectrum Disorders (FASDs) (2014). Available online at: https://www.cdc.gov/ncbddd/fasd/index.html.
16. May PA, Hasken JM, Blankenship J, Marais AS, Joubert B, Cloete M, et al. Breastfeeding and maternal alcohol use: Prevalence and effects on child outcomes and fetal alcohol spectrum disorders. Reprod Toxicol. (2016) 63:13–21. doi: 10.1016/j.reprotox.2016.05.002
17. Giglia R, Binns C. Alcohol and lactation: A systematic review. Nutr Dietetics. (2006) 63:103–16. doi: 10.1111/j.1747-0080.2006.00056.x
18. Aliyu MH, Wilson RE, Zoorob R, Brown K, Alio AP, Clayton H, et al. Prenatal alcohol consumption and fetal growth restriction: potentiation effect by concomitant smoking. Nicot Tob Res. (2009) 11:36–43. doi: 10.1093/ntr/ntn014
19. Odendaal HJ, Steyn DW, Elliott A, Burd L. Combined effects of cigarette smoking and alcohol consumption on perinatal outcome. Gynecol Obstet Invest. (2009) 67:1–8. doi: 10.1159/000150597
20. Odendaal H, Wright C, Schubert P, Boyd TK, Robbers DJ, Brink L, et al. Associations of maternal smoking and drinking with fetal growth and placental abruption. Eur J Obstet Gynecol Reprod Biol. (2020) 253:95–102. doi: 10.1016/j.ejogrb.2020.07.018
21. Illangasekare S, Burke J, Chander G, Gielen A. The syndemic effects of intimate partner violence, HIV/AIDS, and substance abuse on depression among low-income urban women. J Urban Health. (2013) 90:934–47. doi: 10.1007/s11524-013-9797-8
22. Gilbert L, Raj A, Hien D, Stockman J, Terlikbayeva A, Wyatt G. Targeting the SAVA (Substance abuse, violence, and AIDS) syndemic among women and girls: A global review of epidemiology and integrated interventions. J Acquir Immune Defic Syndr. (2015) 69 Suppl 1:S118–27. doi: 10.1097/QAI.0000000000000626
23. Salihu HM, Aliyu MH, Pierre-Louis BJ, Alexander GR. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J. (2003) 7:219–27. doi: 10.1023/A:1027319517405
24. Cnattingius S. The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicot Tobacco Res. (2004) 6:125–40. doi: 10.1080/14622200410001669187
25. Gunn JKL, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. (2016) 6:e009986. doi: 10.1136/bmjopen-2015-009986
26. El Marroun H, Brown QL, Lund IO, Coleman-Cowger VH, Loree AM, Chawla D, et al. An epidemiological, developmental and clinical overview of cannabis use during pregnancy. Prev Med (Baltim). (2018) 116:1–5. doi: 10.1016/j.ypmed.2018.08.036
27. McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. New Engl J Med. (2016) 375:2468–79. doi: 10.1056/NEJMra1600879
28. Fish EW, Murdaugh LB, Zhang C, Boschen KE, Boa-Amponsem O, Mendoza-Romero HN, et al. Cannabinoids exacerbate alcohol teratogenesis by a CB1-hedgehog interaction. Sci Rep. (2019) 9:16057. doi: 10.1038/s41598-019-52336-w
29. NIAAA. Using both marijuana and alcohol during early pregnancy may increase the likelihood of disrupting fetal development. Bethesda, MD, USA: National Institute on Alcohol Abuse and Alcoholism (NIAAA (2019). Available at: https://www.niaaa.nih.gov/news-events/news-releases/marijuana-and-alcohol-use-during-pregnancy-and-fetal-development.
30. MAP: See the states where marijuana is legal (2024). Available online at: https://www.nbcnews.com/news/us-news/map-see-if-marijuana-legal-your-state-n938426.
31. Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. (2017) 317:207. doi: 10.1001/jama.2016.17383
32. Bantjes J, Myers B, Parry C. Liberalising cannabis legislation in South Africa: Potential public health consequences for adolescents and pregnant women. S Afr Med J. (2022) 112:393–4. doi: 10.7196/SAMJ.2022.v112i6.16521
33. Petersen Williams P. Liberalising cannabis legislation in South Africa: cautions to include breastfeeding mothers. South Afr Med J. (2022) 112(11):839. doi: 10.7196/SAMJ.2022.v112i11.16684
34. Parry C, Myers B, Caulkins J. Decriminalisation of recreational cannabis in South Africa. Lancet. (2019) 393:1804–5. doi: 10.1016/S0140-6736(19)30011-X
35. Williams PP, Washio Y, Myers B, Jaspan H, Browne FA, Wechsberg WM, et al. Cannabis use and breastfeeding: Do we know enough? S Afr J Psychol. (2019) 50(1):7–10. doi: 10.1177/0081246319893934
36. Lind JN, Interrante JD, Ailes EC, Gilboa SM, Khan S, Frey MT, et al. Maternal use of opioids during pregnancy and congenital malformations: A systematic review. Pediatrics. (2017) 139(6):e20164131. doi: 10.1542/peds.2016-4131
37. John N, Casey SE, Carino G, McGovern T. Lessons never learned: Crisis and gender-based violence. Dev World Bioeth. (2020) 20(2):65–8. doi: 10.1111/dewb.12261
38. El-Sadr WM, Justman J. Africa in the path of covid-19. N Engl J Med. (2020) 383(3):e11. doi: 10.1056/NEJMp2008193
39. CDC. Social Distancing, Quarantine, and Isolation (2020). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html.
40. UN News. COVID-19 could lead to millions of unintended pregnancies, new UN-backed data reveals. UN News (2020). Available at: https://news.un.org/en/story/2020/04/1062742.
41. Ruyak S, Roberts MH, Chambers S, Ma X, DiDomenico J, de la Garza R, et al. The effect of the COVID-19 pandemic on substance use patterns and physiological dysregulation in pregnant and postpartum women. Alcohol: Clin Exp Res. (2023) 47:1088–99. doi: 10.1111/acer.15077
Keywords: maternal, infant, substance and alcohol use, contextual, perinatal
Citation: Washio Y, Petersen Williams P and Isaacs KR (2024) Editorial: Maternal substance and alcohol use and contextual issues. Front. Psychiatry 15:1432117. doi: 10.3389/fpsyt.2024.1432117
Received: 13 May 2024; Accepted: 21 June 2024;
Published: 23 July 2024.
Edited and Reviewed by:
Stefan Borgwardt, University of Lübeck, GermanyCopyright © 2024 Washio, Petersen Williams and Isaacs. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yukiko Washio, ywashio@rti.org